Current progress on gene therapy for primary immunodeficiencies. (2013)
Attributed to:
Development of a lentiviral vector for gene therapy of ADA deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/gt.2013.21
PubMed Identifier: 23719067
Publication URI: http://europepmc.org/abstract/MED/23719067
Type: Journal Article/Review
Volume: 20
Parent Publication: Gene therapy
Issue: 10
ISSN: 0969-7128